Patients with a high risk of developing CFRD may benefit from increased monitoring, dietary change, intermittent insulin treatment during illness, steroid treatment, and finally, better outcomes in managing this challenging disease. The gene discussed is INS; the disease is cystic fibrosis-related diabetes.